December 1, 2022
On November 30, the Minnesota Department of Health (MDH) announced that it will add irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying medical conditions for participation in Minnesota’s Medical Cannabis Program.
The new qualifying conditions will take effect August 1, 2023.
No petitions for new delivery methods were considered this year. Petitions for gastroparesis and opioid use disorder were not approved.
As in past years, MDH conducted a formal petitioning process to solicit public input on potential qualifying medical conditions and delivery methods for medicine. Minnesotans submitted petitions in June and July. Following that, the process moved into a public comment period and a review panel. MDH staff prepared reports that summarized research pertaining to the use of medical cannabis for each proposed condition.
Click here to see the entire list of qualifying conditions.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.